Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$312.8K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 13 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 42 most recent Form 4 transactions.
| May 21 | ALKS | Alkermes plc. | MEXER | 6,142 | — | — | +45.3% | Open the original filing on SEC.gov |
| May 20 | ALKS | Alkermes plc. | AGRANT◆ | 5,409 | — | — | — | Open the original filing on SEC.gov |
| May 20 | ALKS | Alkermes plc. | AGRANT◆ | 11,538 | — | — | — | Open the original filing on SEC.gov |
| May 14 | COLL | Collegium Pharmaceutical,… | AGRANT | 8,741 | — | — | +48.5% | Open the original filing on SEC.gov |
| May 13 | COLL | Collegium Pharmaceutical,… | SSELL | 4,500 | $35.97 | $161.9K | -20.0% | Open the original filing on SEC.gov |
| Apr 11 | ALKS | Alkermes plc. | MEXER◆ | 3,751 | — | — | — | Open the original filing on SEC.gov |
| Apr 11 | ALKS | Alkermes plc. | FTAX | 901 | $33.36 | $30.1K | -6.2% | Open the original filing on SEC.gov |
| Apr 11 | ALKS | Alkermes plc. | MEXER | 3,751 | — | — | +35.0% | Open the original filing on SEC.gov |
| Jan 6 | EYPT | EyePoint Pharmaceuticals,… | MEXER◆ | 75,133 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | EYPT | EyePoint Pharmaceuticals,… | MEXER | 75,133 | — | — | +34.3% | Open the original filing on SEC.gov |
| Jan 5 | EYPT | EyePoint Pharmaceuticals,… | MEXER◆ | 12,666 | — | — | — | Open the original filing on SEC.gov |
| Jan 5 | EYPT | EyePoint Pharmaceuticals,… | MEXER | 12,666 | — | — | +6.1% | Open the original filing on SEC.gov |
| Jan 2 | EYPT | EyePoint Pharmaceuticals,… | AGRANT◆ | 40,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 4, 2025 | EYPT | EyePoint Pharmaceuticals,… | SSELL◷ | 9,300 | $15.11 | $140.5K | -4.3% | Open the original filing on SEC.gov |
| Nov 28, 2025 | EYPT | EyePoint Pharmaceuticals,… | SSELL◷ | 500 | $14.95 | $7.5K | -0.2% | Open the original filing on SEC.gov |
| Nov 26, 2025 | EYPT | EyePoint Pharmaceuticals,… | SSELL◷ | 200 | $14.95 | $3K | <0.1% | Open the original filing on SEC.gov |
| Jul 10, 2025 | EYPT | EyePoint Pharmaceuticals,… | MEXER◆ | 11,111 | — | — | — | Open the original filing on SEC.gov |
| Jul 10, 2025 | EYPT | EyePoint Pharmaceuticals,… | MEXER | 11,111 | — | — | +5.4% | Open the original filing on SEC.gov |
| Jul 2, 2025 | EYPT | EyePoint Pharmaceuticals,… | GGIFT◆ | 27,270 | — | — | — | Open the original filing on SEC.gov |
| Jul 2, 2025 | EYPT | EyePoint Pharmaceuticals,… | GGIFT◆ | 27,270 | — | — | — | Open the original filing on SEC.gov |
| Jul 2, 2025 | EYPT | EyePoint Pharmaceuticals,… | GGIFT◆ | 15,278 | — | — | — | Open the original filing on SEC.gov |
| Jul 2, 2025 | EYPT | EyePoint Pharmaceuticals,… | GGIFT◆ | 15,278 | — | — | — | Open the original filing on SEC.gov |
| Jul 2, 2025 | EYPT | EyePoint Pharmaceuticals,… | GGIFT◆ | 103,308 | — | — | — | Open the original filing on SEC.gov |
| Jul 2, 2025 | EYPT | EyePoint Pharmaceuticals,… | GGIFT◆ | 103,308 | — | — | — | Open the original filing on SEC.gov |
| Jul 2, 2025 | EYPT | EyePoint Pharmaceuticals,… | GGIFT◆ | 55,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 2, 2025 | EYPT | EyePoint Pharmaceuticals,… | GGIFT◆ | 55,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 2, 2025 | EYPT | EyePoint Pharmaceuticals,… | GGIFT◆ | 31,165 | — | — | — | Open the original filing on SEC.gov |
| Jul 2, 2025 | EYPT | EyePoint Pharmaceuticals,… | GGIFT◆ | 31,165 | — | — | — | Open the original filing on SEC.gov |
| May 31, 2025 | ALKS | Alkermes plc. | MEXER◆ | 8,013 | — | — | — | Open the original filing on SEC.gov |
| May 31, 2025 | ALKS | Alkermes plc. | FTAX | 1,924 | $30.61 | $58.9K | -15.2% | Open the original filing on SEC.gov |
| May 31, 2025 | ALKS | Alkermes plc. | MEXER | 8,013 | — | — | +173.6% | Open the original filing on SEC.gov |
| May 21, 2025 | ALKS | Alkermes plc. | AGRANT◆ | 6,142 | — | — | — | Open the original filing on SEC.gov |
| May 21, 2025 | ALKS | Alkermes plc. | AGRANT◆ | 13,474 | — | — | — | Open the original filing on SEC.gov |
| May 15, 2025 | COLL | Collegium Pharmaceutical,… | AGRANT | 9,791 | — | — | +76.9% | Open the original filing on SEC.gov |
| Apr 11, 2025 | ALKS | Alkermes plc. | MEXER◆ | 3,752 | — | — | — | Open the original filing on SEC.gov |
| Apr 11, 2025 | ALKS | Alkermes plc. | MEXER◆ | 2,323 | — | — | — | Open the original filing on SEC.gov |
| Apr 11, 2025 | ALKS | Alkermes plc. | FTAX | 901 | $27.00 | $24.3K | -16.3% | Open the original filing on SEC.gov |
| Apr 11, 2025 | ALKS | Alkermes plc. | MEXER | 3,752 | — | — | +212.6% | Open the original filing on SEC.gov |
| Apr 11, 2025 | ALKS | Alkermes plc. | FTAX | 558 | $27.00 | $15.1K | -24.0% | Open the original filing on SEC.gov |
| Apr 11, 2025 | ALKS | Alkermes plc. | MEXER | 2,323 | — | — | — | Open the original filing on SEC.gov |